Research articleThe metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients
References (15)
- et al.
Monoamine metabolism in lumbar CSF: the question of their origin in relation to clinical studies
Brain Res.
(1974) - et al.
Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and α-substituted catecholamines
Biochem. Pharmacol.
(1982) - et al.
l-Threo-3,4-dihydroxyphenylserine (DOPS) aldolase: a new enzyme cleaving DOPS into protocatechualdehyde and glycine
Biochem. Biophys. Res Commun.
(1987) - et al.
Multi-electrode detection system for determination of neurotransmitters
- et al.
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?
Neurology
(1987) - et al.
Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol
Science
(1983) - et al.
The mechanism of perturbation in monoamine metabolism by l-DOPA therapy: in vivo and in vitro studies
J. Neural Transm. [GenSect]
(1992)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1996 Published by Elsevier B.V.